Shandong Xinhua Pharmaceutical Company Limited
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for act… Read more
Market Cap & Net Worth: Shandong Xinhua Pharmaceutical Company Limited (SHNXY)
Shandong Xinhua Pharmaceutical Company Limited (PINK:SHNXY) has a market capitalization of $900.00 Million ($900.00 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #4968 globally and #3012 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Xinhua Pharmaceutical Company Limited's stock price $18.19 by its total outstanding shares 49477700 (49.48 Million).
Shandong Xinhua Pharmaceutical Company Limited Market Cap History: 2022 to 2025
Shandong Xinhua Pharmaceutical Company Limited's market capitalization history from 2022 to 2025. Data shows growth from $867.39 Million to $900.00 Million (1.62% CAGR).
Shandong Xinhua Pharmaceutical Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Xinhua Pharmaceutical Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Shandong Xinhua Pharmaceutical Company Limited's market cap is 0.11 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.91x
Shandong Xinhua Pharmaceutical Company Limited's market cap is 1.91 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $867.39 Million | $7.50 Billion | $411.06 Million | 0.12x | 2.11x |
| 2023 | $880.96 Million | $8.10 Billion | $496.51 Million | 0.11x | 1.77x |
| 2024 | $900.00 Million | $8.47 Billion | $470.02 Million | 0.11x | 1.91x |
Competitor Companies of SHNXY by Market Capitalization
Companies near Shandong Xinhua Pharmaceutical Company Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Shandong Xinhua Pharmaceutical Company Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shandong Xinhua Pharmaceutical Company Limited Historical Marketcap From 2022 to 2025
Between 2022 and today, Shandong Xinhua Pharmaceutical Company Limited's market cap moved from $867.39 Million to $ 900.00 Million, with a yearly change of 1.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $900.00 Million | 0.00% |
| 2024 | $900.00 Million | +2.16% |
| 2023 | $880.96 Million | +1.56% |
| 2022 | $867.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shandong Xinhua Pharmaceutical Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $900.00 Million USD |
| MoneyControl | $900.00 Million USD |
| MarketWatch | $900.00 Million USD |
| marketcap.company | $900.00 Million USD |
| Reuters | $900.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.